Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 22 days ago
Share
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease
400 patients around the world
Available in
Chile, United States
Karuna Therapeutics
400
Patients around the world
This study is for people with
Alzheimer disease
Requirements for the patient
To 90 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
ADEPT-2
Sponsor
Karuna Therapeutics
Conditions
Alzheimer disease
Requirements
To 90 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06126224
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent